Please assess the completion status of the following clinical trial:

Trial Title: Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patient has a documented clinical diagnosis of Generalized Anxiety Disorder.~* Be able to understand and comply with the requirements of the study.~* Able to understand and provide written informed consent~Exclusion Criteria:~* Patients (female) must not be pregnant or lactating~* Current or past diagnosis of stroke or transient ischemic attack (TIA).

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).